These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 27359253

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Linkage analysis identifies a locus for plasma von Willebrand factor undetected by genome-wide association.
    Desch KC, Ozel AB, Siemieniak D, Kalish Y, Shavit JA, Thornburg CD, Sharathkumar AA, McHugh CP, Laurie CC, Crenshaw A, Mirel DB, Kim Y, Cropp CD, Molloy AM, Kirke PN, Bailey-Wilson JE, Wilson AF, Mills JL, Scott JM, Brody LC, Li JZ, Ginsburg D.
    Proc Natl Acad Sci U S A; 2013 Jan 08; 110(2):588-93. PubMed ID: 23267103
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Genome-wide linkage analysis of von Willebrand factor plasma levels: results from the GAIT project.
    Souto JC, Almasy L, Soria JM, Buil A, Stone W, Lathrop M, Blangero J, Fontcuberta J.
    Thromb Haemost; 2003 Mar 08; 89(3):468-74. PubMed ID: 12624629
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Genetic determinants of enhanced von Willebrand factor clearance from plasma.
    Seidizadeh O, Baronciani L, Pagliari MT, Cozzi G, Colpani P, Cairo A, Siboni SM, Biguzzi E, Peyvandi F.
    J Thromb Haemost; 2023 May 08; 21(5):1112-1122. PubMed ID: 36754679
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Evaluation of the Utility of von Willebrand Factor Propeptide in the Differential Diagnosis of von Willebrand Disease and Acquired von Willebrand Syndrome.
    Stufano F, Boscarino M, Bucciarelli P, Baronciani L, Maino A, Cozzi G, Peyvandi F.
    Semin Thromb Hemost; 2019 Feb 08; 45(1):36-42. PubMed ID: 29913537
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Acquired von Willebrand syndrome: von Willebrand factor propeptide to von Willebrand factor antigen ratio predicts remission status.
    Lee A, Sinclair G, Valentine K, James P, Poon MC.
    Blood; 2014 Jul 31; 124(5):e1-3. PubMed ID: 24951428
    [Abstract] [Full Text] [Related]

  • 15. Factor VIII pharmacokinetics associates with genetic modifiers of VWF and FVIII clearance in an adult hemophilia A population.
    Ogiwara K, Swystun LL, Paine AS, Kepa S, Choi SJ, Rejtö J, Hopman W, Pabinger I, Lillicrap D.
    J Thromb Haemost; 2021 Mar 31; 19(3):654-663. PubMed ID: 33219619
    [Abstract] [Full Text] [Related]

  • 16. von Willebrand factor: evidence for variable clearance in vivo according to Y/C1584 phenotype and ABO blood group.
    Davies JA, Collins PW, Hathaway LS, Bowen DJ.
    J Thromb Haemost; 2008 Jan 31; 6(1):97-103. PubMed ID: 17949477
    [Abstract] [Full Text] [Related]

  • 17. Assessment of von Willebrand factor propeptide improves the diagnosis of von Willebrand disease.
    Casonato A, Daidone V, Padrini R.
    Semin Thromb Hemost; 2011 Jul 31; 37(5):456-63. PubMed ID: 22102187
    [Abstract] [Full Text] [Related]

  • 18. Genetic determinants of VWF clearance and FVIII binding modify FVIII pharmacokinetics in pediatric hemophilia A patients.
    Swystun LL, Ogiwara K, Rawley O, Brown C, Georgescu I, Hopman W, Labarque V, Male C, Thom K, Blanchette VS, Carcao MD, Lillicrap D.
    Blood; 2019 Sep 12; 134(11):880-891. PubMed ID: 31350267
    [Abstract] [Full Text] [Related]

  • 19. Genetic linkage and association analysis in type 1 von Willebrand disease: results from the Canadian type 1 VWD study.
    James PD, Paterson AD, Notley C, Cameron C, Hegadorn C, Tinlin S, Brown C, O'Brien L, Leggo J, Lillicrap D, ASSOCIATION OF HEMOPHILIA CLINIC DIRECTORS OF CANADA.
    J Thromb Haemost; 2006 Apr 12; 4(4):783-92. PubMed ID: 16634747
    [Abstract] [Full Text] [Related]

  • 20. Distribution of von Willebrand factor levels in young women with and without bleeding symptoms: influence of ABO blood group and promoter haplotypes.
    Lethagen S, Hillarp A, Ekholm C, Mattson E, Halldén C, Friberg B.
    Thromb Haemost; 2008 Jun 12; 99(6):1013-8. PubMed ID: 18521502
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.